Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Global Immunotherapy Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Precision Oncology Market - Trends and Growth Opportunities
... decision-support scientist, or other healthcare professional involved in the matching process. Precision oncology aims to provide oncologists with diagnosis, prognosis, and treatment tools to tailor the treatment according to patients’ genetic makeup. Acquiring, storing, and ... Read More
-
Orphan Drugs Market Forecasts to 2030 – Global Analysis By Disease Type (Oncological Diseases, Metabolic Diseases, Hematologic & Immunologic Diseases, Infectious diseases and Neurological diseases), Drug Type (Non-Biologics and Biologics), Sale, Drug, Distribution Channel and By Geography
... By Geography According to Stratistics MRC, the Global Orphan Drugs Market is accounted for $175.8 billion in 2023 and is expected to reach $445.5 billion by 2030 growing at a CAGR of 14.2% during the ... Read More
-
Interferons Market Forecasts to 2030 – Global Analysis By Product (Interferon Gamma, Interferon Beta, Interferon Alpha and Other Products), Application (Multiple Sclerosis, Polycythemia Vera, Hepatitis C, Hepatitis B, Melanoma, Leukemia, AIDS, Kaposi Sarcoma, Renal Cell Carcinoma, Chronic Granulomatous Disease (CGD) and Other Applications), End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies, Homecare and Other End Users) and By Geography
... Carcinoma, Chronic Granulomatous Disease (CGD) and Other Applications), End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies, Homecare and Other End Users) and By Geography According to Stratistics MRC, the Global Interferons Market is ... Read More
-
Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, and Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Orthopedic, Endocrinology, and Others), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... and Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Radioactive tracers have become an essential tool in several industries including healthcare, research, and oil exploration. These tracers consist ... Read More
-
Oncology Clinical Trials Market Size, Share & Trends Analysis Report By Phase Type (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Study, Observational Study, Expanded Access Study), By Region, And Segment Forecasts, 2023 - 2030
... Forecasts, 2023 - 2030 Oncology Clinical Trials Market Growth & Trends The global oncology clinical trials market size is expected to reach USD 19.49 billion by 2030, registering a CAGR of 5.2% from 2023 to ... Read More
-
Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type (Lentivirus, Adenovirus), By Region, And Segment Forecasts, 2024 - 2030
... Trends The global gene therapy market is expected to reach USD 29.51 billion by 2030, registering a CAGR of 19.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. The ... Read More
-
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) - Global Forecast to 2028
... projected to reach USD 1.1 billion by 2028 from USD 0.7 billion in 2023, growing at a CAGR of 8.2% during the forecast period. The projected surge in market growth for the Particle therapy market ... Read More
-
Fecal Calprotectin Test Market, By Assay Type (Enzyme Linked Immunosorbent Assay (ELISA), Enzyme Fluoroimmunoassay, and Quantitative Immune-Chromatography), By Indication (Inflammatory Bowel Disease (IBD) Diagnosis, Colorectal Cancer, Celiac Disease, and others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and others), , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Laboratories, Academic and Research Institutes, and others), , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Inflammation of the digestive system is brought on by the chronic illness of Inflammatory ... Read More
-
France CAR-T Cell Therapy Market By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), Others), By Tumor Type (Hematological Malignancies, Solid Tumors), By Indication (Diffused Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic
... Mantle Cell Lymphoma (MCL), Others), By Treatment Type (Single Treatment, Combination Treatment), By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, By ... Read More
-
France Head and Neck Cancer Market By Type (Diagnostic Methods, Treatment Type), By Diagnostic Methods (Biopsy, Imaging, Endoscopy, Others), By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By Disease Indicati
... Cavity Cancer, Laryngeal Cancer, Oropharyngeal Cancer, Salivary Gland Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer), By Route of Administration (Injectable, Oral), By Therapeutic Class (PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors), By End User (Hospitals, Specialty Clinics, Ambulatory ... Read More
-
Laryngeal Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Biologics, Small Molecules), By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, By Competition
... Cancer Therapeutics Market has valued at USD 3.75 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.30% through 2028. The Global Laryngeal Cancer Therapeutics Market ... Read More
-
Stem Cell Technologies and Applications Market Report 2023-2033
... the industry and its underlying dynamics better. It will be useful for companies that want to expand into different industries or their existing operations in a new region. Growing Government Support Driving Market Growth Growing ... Read More
-
India Cancer Therapeutics Market Assessment, By Applications [Lung Cancer, Blood Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Glioblastoma, Head & Neck Cancer, Malignant Meningioma, Mesothelioma, Melanoma, Others], By Therapeutics [Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Other], By Top Selling Drugs [Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, Others], By End-user [Hospitals, Specialty Clinics, Cancer & Radiation Therapy Centers], By Region, By Opportunities and Forecast, FY2017-FY2031F
... Hormonal Therapy, Other], By Top Selling Drugs [Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, Others], By End-user [Hospitals, Specialty Clinics, Cancer & Radiation Therapy Centers], By Region, ... Read More
-
Non-Melanoma Skin Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 725.7 Million by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2022-2028. Non-melanoma skin cancer (NMSC) refers to the abnormal growth of malignant cells in the upper layer of the ... Read More
-
Acute Myeloid Leukemia Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 2,199.1 Million by 2028, exhibiting a growth rate (CAGR) of 12.7% during 2022-2028. Acute myeloid leukemia (AML) refers to a clonal malignancy leading to the rapid growth of abnormal cells. It ... Read More
-
Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032
... over the years. The most common and widely accepted classification of breast cancer is from an immunohistochemical perspective, based on the expression of the following hormone receptors: estrogen (ER), progesterone (PR), and human epidermal growth ... Read More
-
Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032
... NSCLC, continuous uptake of approved therapies mainly immune checkpoint inhibitors, expected entry of potential premium price emerging therapies and increasing awareness of mutations like KRAS, BRAF, c-Met and others. The total market size of metastatic ... Read More
-
Esophageal Squamous Cell Carcinoma Market Research Report Forecast till 2030
... research exercises and item endorsements, and rising public mindfulness are driving market development. The rising commonness of achalasia help market development because achalasia patients have a higher gamble of Esophageal Squamous Cell Carcinoma than everybody. ... Read More
-
Virtual Oncology Market, By Component (Software, Service, Hardware), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Others (Pancreatic, Ovarian, etc.)), By Application (Precision Medicine, Patient Care Management, Research & Development, Clinical Trials, Diagnosis & Treatment Decision Making, Data Management, Others (Billing Management, Regulatory Compliance etc.)), By End User (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract Research Organizations (CROs), Others (Reference Laboratories, Pharmacies etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... & Development, Clinical Trials, Diagnosis & Treatment Decision Making, Data Management, Others (Billing Management, Regulatory Compliance etc.)), By End User (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract ... Read More
-
Global Biomarkers Market - 2023-2030
... Biomarkers also known as biological markers, is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention. Biomarkers are used for ... Read More
-
HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... and drug resistance mechanisms. In 2022, the United States accounted for the maximum share of the total market of HER2-positive breast cancer in the 7MM was around 60%. The approval of HERCEPTIN marked a turning ... Read More
-
Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the metastatic prostate cancer market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan. The metastatic prostate cancer market report provides current ... Read More
-
Metastatic HR+/HER2− Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032
... breast cancer subtypes. The total market size in the 7MM for HR+/HER2- breast cancer was estimated to be USD 9,200 million in 2022, which is expected to grow by 2032. For the past decade, endocrine ... Read More
-
Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032
... is a localized form of prostate cancer. When prostate cancer is diagnosed at this stage, it means that cancer cells are confined to the prostate and have not yet invaded surrounding tissues or metastasized (spread) ... Read More
Research Assistance
